• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up1.03% Nasdaq Up1.29%

    Merrimack Pharmaceuticals, Inc. (MACK)

    -NasdaqGM
    11.92 Up 0.82(7.39%) May 1, 4:00PM EDT
    |After Hours : 11.45 Down 0.47 (3.94%) May 1, 4:41PM EDT
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2014Sep 30, 2014Jun 30, 2014Mar 31, 2014
    Total Revenue 33,905   28,002   27,815   13,034  
    Cost of Revenue -   -   -   -  
    Gross Profit 33,905   28,002   27,815   13,034  
    Operating Expenses
    Research Development30,744  43,632  33,795  30,324  
    Selling General and Administrative8,277  8,095  7,921  6,224  
    Non Recurring -   -   -   -  
    Others -   -   -   -  
    Total Operating Expenses -   -   -   -  
    Operating Income or Loss (5,116) (23,725) (13,901) (23,514)
    Income from Continuing Operations
    Total Other Income/Expenses Net203  272  181  271  
    Earnings Before Interest And Taxes(4,913)(23,453)(13,720)(23,243)
    Interest Expense4,564  4,585  4,570  4,511  
    Income Before Tax(9,477)(28,038)(18,290)(27,754)
    Income Tax Expense -   -   -   -  
    Minority Interest(219)137  181  169  
    Net Income From Continuing Ops(9,696)(27,901)(18,109)(27,585)
    Non-recurring Events
    Discontinued Operations -   -   -   -  
    Extraordinary Items -   -   -   -  
    Effect Of Accounting Changes -   -   -   -  
    Other Items -   -   -   -  
    Net Income (9,696) (27,901) (18,109) (27,585)
    Preferred Stock And Other Adjustments -   -   -   -  
    Net Income Applicable To Common Shares (9,696) (27,901) (18,109) (27,585)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.